ADHD Drugs To Have Stronger Warning; Include Novartis International AG’s Dexedrine And GlaxoSmithKline Biologicals’s Ritalin

WASHINGTON (AP) -- The Food and Drug Administration on Monday announced changes to the labels for Dexedrine, an amphetamine used to treat attention-deficit hyperactivity disorder and narcolepsy, to warn of possible heart problems it may cause.>>> Discuss This Story